Xing P X, Reynolds K, Pietersz G A, McKenzie I F
Research Centre for Cancer and Transplantation, University of Melbourne, Parkville, Victoria, Australia.
Immunology. 1991 Feb;72(2):304-11.
Monoclonal anti-mucine antibodies BC1, BC2 and BC3 produced using human milk fat globule membrane react with a synthetic peptide p1-24 (PDTRPAPGSTAPPAHGVTSAPDTR) representing the repeating amino acid sequence of the mucin core protein. The minimum epitope recognized by these three monoclonal antibodies (mAb) in p1-24 was contained in the five amino acids APDTR. To analyse the variation of position of the epitope, various modifications of the APDTR sequence were made by synthesizing peptides and testing by direct binding and inhibition enzyme-linked immunosorbent assays. Firstly, peptides p13-32 and C-p13-32, in which the epitope APDTR was placed in the middle instead of the C-terminal as in p1-24, were examined. These peptides had a greater reaction with mAb BC1, BC2 and BC3 compared with the reaction with p1-24. Secondly, A-p1-24 and TSA-p1-24 were made wherein two APDTR epitopes were present--these peptides were shown to bind two IgG antibody molecules. Finally, the contribution of each amino acid in the APDTR epitope was studied using the pepscan polyethylene rods, making all 20 of the amino acid substitutions in each position for SAPDTR (the minimum epitope APDTR with an adjacent amino acid S). In the 120 peptides examined there were some 'permissible' substitutions in A, D and T but not in P or R for BC1 and BC2; there were more 'permissible' substitutions for BC3; different substitution patterns were found with each antibody and some substitutions gave an increased reaction compared with the native peptide SAPDTR. The studies are of value in analysing the reaction of antibodies with epitopes expressed in breast cancer and in determining the antigenicity of synthetic peptides.
利用人乳脂肪球膜制备的单克隆抗粘蛋白抗体BC1、BC2和BC3与一种合成肽p1-24(PDTRPAPGSTAPPAHGVTSAPDTR)发生反应,该合成肽代表粘蛋白核心蛋白的重复氨基酸序列。这三种单克隆抗体(mAb)在p1-24中识别的最小表位包含在五个氨基酸APDTR中。为了分析表位位置的变化,通过合成肽并进行直接结合和抑制酶联免疫吸附测定来对APDTR序列进行各种修饰。首先,检测了肽p13-32和C-p13-32,其中表位APDTR位于中间而非如p1-24那样位于C末端。与p1-24相比,这些肽与mAb BC1、BC2和BC3的反应更强。其次,制备了A-p1-24和TSA-p1-24,其中存在两个APDTR表位——这些肽被证明能结合两个IgG抗体分子。最后,使用肽扫描聚乙烯棒研究了APDTR表位中每个氨基酸的作用,对SAPDTR(最小表位APDTR及其相邻氨基酸S)的每个位置进行了所有20种氨基酸替换。在所检测的120种肽中,对于BC1和BC2,A、D和T存在一些“允许”的替换,但P或R不存在;BC3有更多“允许”的替换;每种抗体发现了不同的替换模式,一些替换与天然肽SAPDTR相比反应增强。这些研究对于分析抗体与乳腺癌中表达的表位的反应以及确定合成肽的抗原性具有重要价值。